VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Milestone: Saipu Bio's Class-1 Stem Cell Therapy for Ischemic Stroke Receives IND Acceptance from CDE
Milestone: Saipu Bio's Class-1 Stem Cell Therapy for Ischemic Stroke Receives IND Acceptance from CDE
May 23, 2026 07:20 CST Updated 10:24
Share:
